< Back to search
Filter
1

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Boston MA, Wilson NC, Chapel Hill NC, Pembroke Pines FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase1, Phase2, Recruiting

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06871176

Recruiting

A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07099391

Phase1, Phase2, Recruiting

Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse

for
Multiple Myeloma
Location: Miami FL
Sponsor: Dickran Kazandjian, MD

Sex: All

Age: 0+

Code: NCT06910124

Phase2, Recruiting

Retina is a Marker for Cerebrovascular Heath

for
Cerebral Small Vessel Diseases,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04753970

Phase1, Phase2, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures

for
Pain Management, Rib Fracture Multiple,
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: All

Age: 18+

Code: NCT07032766

Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for
Multiple Myeloma
Location: New York NY, Charlottesville VA, Tampa FL, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07073547

Phase1, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

for
Colorectal Adenomatous Polyp, Colorectal Carcinoma,
Location: Cleveland OH, Columbus OH, Ann Arbor MI
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05630794

Phase1, Recruiting

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma, Refractory Multiple Myeloma,
Location: San Francisco CA
Sponsor: Alfred Chung, MD

Sex: All

Age: 18+

Code: NCT06348108

Phase1, Recruiting

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06940297

Phase2, Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07105059

Phase1, Recruiting

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Birmingham AL
Sponsor: Susan Bal

Sex: All

Age: 19+

Code: NCT07333261

Phase1, Recruiting

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

for
Myeloma, Multiple Myeloma, Refractory Multiple Myeloma
Location: Boston MA
Sponsor: Omar Nadeem, MD

Sex: All

Age: 18+

Code: NCT06518551

Phase1, Phase2, Recruiting

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

for
Central Nervous System Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05011045

Recruiting

Tissue Collection for Studies of Lymph Cancer

for
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01676805

Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Baltimore MD, Bethesda MD, Buffalo NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

Elranatamab in Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06711705

Phase2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Halifax, Boston MA, New Haven CT, Sherbrooke,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase3, Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Miami FL, Toronto,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase1, Phase2, Recruiting